Maynard Um
-
-
-
-
-
-
-
Jefferies Upgrades BeOne Medicines (ONC) to Buy
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $453 at Citi
-
-
-
-
-
-
-
Bernstein on BeOne Medicines (ONC): 'A Good Opportunity to Buy Now'
-
-
-
-
-
-
-
BofA on BeOne Medicines (ONC): 'we prefer BeOne, given the BTK leadership of Brukinsa and catalyst of BTK CDAC data readout'
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $420 at Jefferies
-
-
-
-
-
-
-
Barclays Starts BeOne Medicines (ONC) at Overweight
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $365 at Guggenheim
-
470,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


